Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Aminopyridine | HCID 10439 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Reactant | 8-Bromo-6-chloro-N-(3-fluoropyridin-4-yl)imidazo[1,2-b]pyridazine-3-carboxamide | HCID 59624495 | — |
| Reactant | HCID 178511674 | HCID 178511674 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 178511624 | HCID 178511624 | 5.3% |
Reaction Steps
A suspension of 5A (20 mg, 0.061 mmol) in THF (1 mL) was treated with pyridin-2-amine (11.54 mg, 0.123 mmol). A solution of potassium t-butoxide (0.123 mL, 0.123 mmol) in THF was added and the reaction was stirred at room temperature. After two hours the solvent was removed under a stream of nitrogen. (trans)-cyclohexane-1,4-diamine (200 mg, 1.751 mmol) was added and the reaction mixture was heated to 160° C. for 3 hours. The solution was cooled to room temperature and diluted with MeOH. The solid residue was filtered and dried. The crude reaction product was dissolved in a small amount of MeOH and purified by reversed phase HPLC (YMC ODS-A 5 um 30×250 mm, 10-90% aqueous methanol containing 0.1% TFA, 25 mL/min, 30 min gradient, monitored at 220 nm). The product (retention time=28.731 minutes) was isolated and lyophilized to dryness to afford 6-((trans-4-aminocyclohexyl)amino)-N-(3-fluoro-4-pyridinyl)-8-(2-pyridinylamino)imidazo[1,2-b]pyridazine-3-carboxamide (1.5 mg, 4.25%). HPLC Rt=3.343 min (YMC S5 ODS 4.6×50 mm, 10-90% aqueous methanol containing 0.2% H3PO4, 4 min gradient, monitored at 220 nm). [M+H+]=462.1.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08389527B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-2653485f4edc49e6b8fcb3cb7e8c698f |
|---|
| Source note | uspto-grants-2013_03 |
|---|